Mohamed Khaled Diab

15PUBLICATIONS
25CO-AUTHORS
Molecular targetsHaematological tumoursBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 25, 2026
Bridging BET bromodomain and immune checkpoint inhibitors through generative bioorganic frameworks for next-generation cancer immunotherapy.

|Sep 24, 2026
ATP is not always pro-inflammatory: rethinking purinergic signalling in cancer and autoimmunity.

|Jul 16, 2026
Recent Overview on the Molecular Hybrids Integrated With Benzosuberone/Benzo[7]annulene Derivatives as Multi-Target Therapeutics.

|Jun 15, 2026
Triazole-Sulfonamide Hybrids as Carbonic Anhydrase Inhibitors: Emerging Chemistry and Bioactivity Insights From 2020 to 2025.

|May 12, 2026
Dual-Function Lipid-Based Nanovector Strategy for Glioblastoma Immunotherapy: STING Activation and M1 Microglia Polarization.

|Feb 13, 2026
Exploring pyrazoline-thiophene hybrids as CDK2 inhibitors: synthesis, mechanism, biological studies, and computational insights.

Heba M Abosalim, Tarek F El-Moselhy, Nabaweya Sharafeldin

Pageof 3

Frequent Collaborators

13 joint publications

Mohamed S Nafie

6 joint publications

Sherif Ashraf Fahmy

4 joint publications

Abdelghafar Mohamed Abu-Elsaoud

3 joint publications

Haytham O Tawfik